Results

Total Results: 1,643 records

Showing results for "factor".

281. Disposition of Comments for CER 175 Total Worker Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/worker-health_disposition-comments.pdf
     May 31, 2016 - This makes comparisons of the complex organizational factor of “integration” highly problematic.

282. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - therapies such as monoclonal antibodies (infliximab, adalimumab, tocilizumab) and tumor necrosis factor … chronic inflammatory diseases, such as antibody production by B cells, production of rheumatic factor … resulting in the production of interleukin 1 beta (IL-1- beta), interleukin 18, and tumor necrosis factor … in chronic inflammatory diseases, such as antibody production by B cells, production of rheumatic factor … ) with moderate to severe active RA who had an inadequate response to at least one tumor necrosis factor

283. Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
     January 01, 2024 - Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events Evidence-based Practice Center Systematic Review Protocol Project Title: Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events I. Background and Purpose of the Systematic Review…

284. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - cases, insulin effects appear to be mediated by the presence of the ApoE4 allele, a genetic risk factor … and/or the presence of the apolipoprotein e4 (ApoE4) allele, which is known to be a genetic risk factor

285. Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
     January 01, 2023 - invasive lobular carcinoma, tumor size 2.1-3 cm, grade 3, ER negative status, Human Epidermal Growth Factor

286. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
     January 01, 2016 - Being African American, Hispanic, American Indian, or Asian American is also a risk factor for T2DM … greater with this intervention than with off-label use of anti-VEGF (vascular endothelial growth factor … The fluocinolone acetonide implant will probably compete with the vascular endothelial growth factor … Vascular endothelial growth factor A. In: GeneCards [internet]. … Clinical policy bulletin: vascular endothelial growth factor inhibitors for ocular neovascularization

287. Amended Protocol: Maternal and Childhood Outcomes Associated with the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/wic-outcomes-nutrition-protocol-amended.pdf
     October 01, 2020 - Amended Protocol: Maternal and Childhood Outcomes Associated with the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) 1 Evidence-based Practice Center Systematic Review Protocol Systematic Review of Maternal and Childhood Outcomes associated with the Special Supplemental Nutrition Pr…

288. Peripheral-Artery-Disease-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
     January 31, 2013 - Source: www.effectivehealthcare.ahrq.gov Originally published online: January 31, 2012; Amended January 31, 2013 Evidence-based Practice Center Systematic Review Protocol Project Title: Treatment Strategies for Patients With Peripheral Artery Disease (PAD) Amendment Date(s): January 31, 2013 (Amendment Detai…

289. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
     September 01, 2011 - Five cohort studies reported that sex was not a significant modifying factor of medical treatment outcomes … factors as modifying factors of medical treatment outcomes. - Sex was not a significant modifying factor

290. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/tympanostomy-tubes_research-protocol.pdf
     November 16, 2015 - Untitled   Source: www.effectivehealthcare.ahrq.gov Published online: November 16, 2015 Evidence-based Practice Center Systematic Review Protocol Project Title: Tympanostomy Tubes I. Background and Objectives for the Systematic Review Uncertainty in the comparative effectiveness of tym…

291. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-2010_research-protocol.pdf
     January 01, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: May 6, 2011 Evidence-based Practice Center Systematic Review Protocol Project Title: Strategies To Reduce Cesarean I. Background and Objectives for the Systematic Review Recent rep…

292. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
     November 30, 2011 - 70 to 80 percent) compared with those with genotype 1 (SVR of 40 to 50 percent). 14,15 Another factor

293. Renal-Function Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
     June 13, 2013 - In the absence of clear ECG findings, troponin levels are often a key factor in making the correct diagnosis … Therefore, troponin is not only the diagnostic assay but considered as one clinical factor for definition … While troponin is one factor often considered in evaluation of MI/ACS, by itself, troponin is neither

294. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - synaptic plasticity and synaptogenesis, partly mediated by increased brain-derived neurotrophic factor … antidepressant properties include mammalian target of rapamycin (mTOR) and eukaryotic elongation factor … this intervention to produce a large impact on disparate populations, but noted that cost could be a factor … Intervention: Seven modules comprise the SPARX (Smart, Positive, Active, Realistic, X- factor) thoughts-depression-intervention … The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine.

295. Behavioral Programs for Type 2 Diabetes Mellitus: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
     November 01, 2016 - Behavioral Programs for Type 2 Diabetes Mellitus: Current State of the Evidence Behavioral Programs for Type 2 Diabetes Mellitus: Current State of the Evidence Focus of This Summary This is a summary of a systematic review evaluating the evidence about factors that contribute to the effectiveness of behavioral p…

296. Labor-Nitrous-Oxide Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_executive.pdf
     August 01, 2012 - 1 Comparative Effectiveness Review Number 67 Nitrous Oxide for the Management of Labor Pain Executive Summary Background More than 4 million births occur in the United States each year; in 2008, there were 4,247,694 births.1 The most commonly used labor pain management method in the United States is epidural…

297. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
     March 13, 2012 - We anticipate that the single most important factor limiting the applicability of a finding of a protective

298. Screening and Diagnosing Gestational Diabetes Mellitus Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_disposition-comments.pdf
     January 01, 2020 - #10 General The authors should bring the issue of changing the definition of 'mild GDM' as a 'risk factor … In the chapter addressing risk-factor based screening (page 32 line 27) it is not clear to me why the … Universal vs. risk factor- based screening for gestational diabetes mellitus: detection rates, gestation … research should be directed at identifying, through a combination of clinical and biochemical risk factor

299. Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mental-illness-heart/research

300. Disposition of Comments for CER 168 Infantile Hemangioma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
     January 15, 2016 - Families and clinicians making treatment decisions should also factor in elements such as lesion size … but we have noted the route of administration in all relevant tables and noted compounding as a factor … Families and clinicians making treatment decisions should also factor in elements such as lesion size